Clinical Trial

A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Name: A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease — clinical trial record (NCT06980142)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Explore the Efficacy and Safety of CM512 Injection in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Trial Details

NCT Number	NCT06980142
Lead Sponsor	Keymed Biosciences Co.Ltd
Conditions	Chronic Obstructive Pulmonary Disease
Enrollment	204 participants
Start Date	2025-06-20
Primary Completion	2028-03-17 (estimated)
Study Completion	2028-03-17 (estimated)
Updated on ClinicalTrials.gov	2025-05-20